Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...

While overall cancer incidence was lower among patients with vs without RA, rates of postcancer mortality were significantly higher among this group.

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

Very sick patients who get a bone marrow transplant at Medical University of South Carolina survive at a much higher rate ...

The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...

Patients with advanced bladder cancer treated with an immunosuppressant drug were a third less likely to see the disease return and more likely to survive for longer than patients who were given ...

The data she presented also shows that the survival rate for cervical, breast, prostate, and thyroid cancer in Korea ranges ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

Each year, approximately 15,000 children in the United States are diagnosed with cancer.Hasbro Children's Hospital treats between 60 to 70 new pediatric cancer ...

“Patients treated with durvalumab before and after surgery had both significantly higher survival rates and lower risks of the cancer returning and didn’t face any additional serious side effects.

Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive, according to a “game-changer” study. Patients with advanced ...